Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities.
Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities.
Shin W, Hompesch M, Byeon J, Kang S, Choi J, Baek S. Diabetes Obes Metab. 2023 Jun 13. doi: 10.1111/dom.15162.
in cat NOT
Stay Connected
Would you like to receive updates from ProSciento?
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information, such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.
Analytics cookies used:
LinkedIn
Twitter
Facebook
Google Tag Manager
GStatic
Google AdWords
Please enable Strictly Necessary Cookies first so that we can save your preferences!
Privacy Policy
More information about our Cookie Policy can be found within our Privacy Policy